Desmoid tumour
Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Fibromatosis, Aggressive / Desmoid Tumor / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB00675 | Tamoxifen | A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17109 | Tegavivint | 1 | Completed | 1 |
DB00619 | Imatinib | 1 / 2 | Active Not Recruiting | 1 |
DB00619 | Imatinib | 1 / 2 | Completed | 1 |
DB09035 | Nivolumab | 1 / 2 | Completed | 1 |
DB00877 | Sirolimus | 1 / 2 | Completed | 2 |
DB15310 | Vactosertib | 1 / 2 | Active Not Recruiting | 1 |
DB01005 | Hydroxyurea | 2 | Withdrawn | 1 |
DB00619 | Imatinib | 2 | Completed | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB00563 | Methotrexate | 2 | Completed | 1 |
DB12005 | Nirogacestat | 2 | Active Not Recruiting | 1 |
DB12005 | Nirogacestat | 2 | Completed | 1 |
DB12005 | Nirogacestat | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB00605 | Sulindac | 2 | Completed | 1 |
DB01268 | Sunitinib | 2 | Completed | 1 |
DB00675 | Tamoxifen | 2 | Completed | 1 |
DB00539 | Toremifene | 2 | Completed | 1 |
DB00539 | Toremifene | 2 | Unknown Status | 1 |
DB00570 | Vinblastine | 2 | Completed | 1 |
DB00997 | Doxorubicin | 3 | Recruiting | 1 |
DB12005 | Nirogacestat | 3 | Active Not Recruiting | 1 |
DB00398 | Sorafenib | 3 | Completed | 1 |
DB12005 | Nirogacestat | Not Available | Available | 1 |
DB12005 | Nirogacestat | Not Available | No Longer Available | 1 |